Key Takeaways
- • Jiangsu Yiyou Robot Technology (Eyoubot) closed a CNY 200 million (approximately $28–41 million USD) Series B funding round, representing significant capital injection into China's humanoid robot component supply chain.
- • The company specializes in high-performance joint modules for humanoid robots, including planetary, harmonic, and linear variants, positioning it as a critical domestic supplier of core robotic components in China.
- • Eyoubot secured CNY 50 million in Series A funding in March 2025 led by Pudong Angel Fund and Zhangke Yaokun Fund, with backing from TCL Venture Capital, Daosheng Capital, and Wuxi Jinkong Qiyuan Investment; the company planned expansion to Shanghai's Zhangjiang Robot Valley following that round.
- • Production capacity is scaling aggressively, rising from 30,000 units in 2024 to an expected 180,000 units in 2025, reflecting accelerated demand for humanoid robot components as the sector enters mass production stages.
- • Eyoubot serves as the designated supplier for Zhiyuan Robot A2 series, recognized as the world's first mass-produced humanoid robots, establishing a strategic anchor position in emerging commercialization of humanoid robotics.
Summary
Jiangsu Yiyou Robot Technology, operating under the brand Eyoubot, has completed a Series B funding round valued at CNY 200 million, signaling sustained institutional confidence in China's humanoid robotics supply chain. The company, founded in 2018, specializes in the research, development, manufacturing, and sales of drive systems and joint modules that form the mechanical foundation of humanoid robot motion control systems.
Eyoubot's product portfolio addresses the full spectrum of joint requirements for humanoid robotic systems. The company manufactures planetary joint modules, harmonic joint modules, and humanoid linear joint modules, each engineered for specific load-bearing and precision movement applications. These components are deployed across collaborative robotic arms, medical devices, and industrial automation platforms. Beyond hardware, Eyoubot offers a wearable teleoperation control system enabling real-time remote robot movement control, expanding its value proposition beyond static component supply.
The company's technical foundation reflects deep domain expertise: its core team possesses over 20 years of cumulative experience in robot research and development. Prior to this Series B round, Eyoubot secured CNY 50 million in Series A funding in March 2025, led by Pudong Angel Fund and Zhangke Yaokun Fund and supported by TCL Venture Capital, Daosheng Capital, and Wuxi Jinkong Qiyuan Investment. That capital was earmarked for core technology R&D and production capacity expansion, with the company establishing operations in Shanghai's Zhangjiang Robot Valley.
Manufacturing scale is accelerating sharply. Eyoubot's production capacity is projected to reach 180,000 units in 2025, a sixfold increase from 30,000 units in 2024, reflecting market-driven demand growth as humanoid robotics transitions from prototype to commercial production. The company's strategic positioning as the designated component supplier for the Zhiyuan Robot A2 series—identified as the world's first mass-produced humanoid robots—anchors Eyoubot within the emerging commercialization wave in China's robotics sector.
Eyoubot's product portfolio addresses the full spectrum of joint requirements for humanoid robotic systems. The company manufactures planetary joint modules, harmonic joint modules, and humanoid linear joint modules, each engineered for specific load-bearing and precision movement applications. These components are deployed across collaborative robotic arms, medical devices, and industrial automation platforms. Beyond hardware, Eyoubot offers a wearable teleoperation control system enabling real-time remote robot movement control, expanding its value proposition beyond static component supply.
The company's technical foundation reflects deep domain expertise: its core team possesses over 20 years of cumulative experience in robot research and development. Prior to this Series B round, Eyoubot secured CNY 50 million in Series A funding in March 2025, led by Pudong Angel Fund and Zhangke Yaokun Fund and supported by TCL Venture Capital, Daosheng Capital, and Wuxi Jinkong Qiyuan Investment. That capital was earmarked for core technology R&D and production capacity expansion, with the company establishing operations in Shanghai's Zhangjiang Robot Valley.
Manufacturing scale is accelerating sharply. Eyoubot's production capacity is projected to reach 180,000 units in 2025, a sixfold increase from 30,000 units in 2024, reflecting market-driven demand growth as humanoid robotics transitions from prototype to commercial production. The company's strategic positioning as the designated component supplier for the Zhiyuan Robot A2 series—identified as the world's first mass-produced humanoid robots—anchors Eyoubot within the emerging commercialization wave in China's robotics sector.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.